Home
Conditions
Skin Diseases, Vascular

Clinical trial condition

Skin Diseases, Vascular

Explore clinical trials studying Skin Diseases, Vascular. Study availability and eligibility vary by location and protocol.

953 public trials 192 recruiting studies

Refine in advanced search Browse all conditions

Skin Diseases, Vascular trial results

Completed

MRI Superficial Temporal Artery

NCT00188448

Conditions: Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +14 more
Locations: Toronto General Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides

NCT00430105

Conditions: ANCA Associated Systemic Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
Locations: Not specified

View Trial Details

Completed

Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.

NCT00138983

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, Arthritis, +32 more
Locations: UMC Utrecht Utrecht, Netherlands

View Trial Details

Completed

NAET Screening for Food Allergy, Sensitivity and Intolerances Using IgE-Specific Antigen Test and NST- NAET®

NCT00275795

Conditions: Acne Vulgaris, Acneiform Eruptions, Back Pain, +22 more
Locations: NAET Pain Clinic Buena Park, California, United States

View Trial Details

Completed

A Trial of Point of Care Information in Ambulatory Pediatrics

NCT00368823

Conditions: Acute Otitis Media, Allergic Rhinitis, Bronchial Diseases, +34 more
Locations: Roosevelt Pediatric Clinic Seattle, Washington, United States

Skagit Valley Pediatrics Skagit Valley, Washington, United States

View Trial Details

Completed

Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis

NCT00293072

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +11 more
Locations: Addenbrooke's Hospital Cambridge, Cambridgeshire, United Kingdom

View Trial Details

Completed

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

NCT00048776

Conditions: Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +12 more
Locations: Advanced Medical Clinical Therapeutics Anchorage, Alaska, United States

Advanced Medical Research Institute Fresno, California, United States

Madera Family Medical Group Madera, California, United States

Connecticut Children's Medical Center Hartford, Connecticut, United States

View all 19 locations

View Trial Details

Completed

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

NCT00048763

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Livedoid Vasculopathy, +8 more
Locations: Advanced Medical Clinical Therapeutics Anchorage, Alaska, United States

Advanced Medical Research Institute Fresno, California, United States

Madera Family Medical Group Madera, California, United States

Connecticut Children's Medical Center Hartford, Connecticut, United States

View all 18 locations

View Trial Details

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis

NCT00004786

Conditions: Arthritis, Cardiovascular Diseases, Connective Tissue Diseases, +18 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

Avacostar - (PASS)

NCT05897684

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +8 more
Locations: Charité University Medicine Berlin, Germany

University Hospital of Cologne Cologne, Germany

Municipal Hospital Dresden Dresden, Germany

University Hospital Essen Essen, Germany

View all 35 locations

View Trial Details

Skin Diseases, Vascular

Skin Diseases, Vascular trial results

Related conditions